Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); Positive View on Vascepa

September 11, 2012 8:18 AM EDT Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $26.00.

Analyst, Ritu Baral, said, "Reiterate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login